Griffiths Graham 4
4 · Barinthus Biotherapeutics plc. · Filed Feb 5, 2025
Insider Transaction Report
Form 4
Griffiths Graham
Chief Business Officer
Transactions
- Award
Share Option (Right to Buy)
2025-02-03+200,000→ 200,000 totalExercise: $1.00Exp: 2035-02-03→ Ordinary Shares (200,000 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 3, 2026.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.